Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study.
about
Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart diseaseNew treatments in acute ischemic strokeAspirin and Reye's syndrome: is the response appropriate?Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acidAntithrombotic drugs in secondary stroke prevention among a community dwelling older populationAortic arch atheroma and the risk of strokeAmaurosis fugax caused by heritable thrombophilia-hypofibrinolysis in cases without carotid atherosclerosis: thromboprophylaxis prevents subsequent transient monocular partial blindnessAntiplatelet therapy in secondary stroke prevention.Warfarin therapy: in need of improvement after all these years.Radiofrequency radiation exposure and other environmental concernsLong-term treatment with warfarin in Chinese population.Appropriateness of treatment recommendations for PPI in hospital discharge letters.CYP4F2 genetic variant alters required warfarin doseImplementation of antithrombotic management in atrial fibrillation.Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial.Market Access Advancements and Challenges in "Drug-Companion Diagnostic Test" Co-Development in EuropeCost effectiveness of therapies for atrial fibrillation. A review.A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial FibrillationSecondary prevention of ischemic cerebrovascular disease. What is the evidence?Cryptogenic stroke, aortic arch atheroma, patent foramen ovale, and the risk of stroke.Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack.Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics.Drug adherence in patients taking oral anticoagulation therapy.Optimizing the duration of anticoagulation therapy for venous thrombosis.Amaurosis fugax: associations with heritable thrombophilia.Aortic Source of Brain Embolism.Hemorrhage after ischemic stroke - relation to age and previous hemorrhage in a nationwide cohort of 58,868 patients.Correlation between Rs2108622 Locus of CYP4F2 Gene Single Nucleotide Polymorphism and Warfarin Dosage in Iranian Cardiovascular Patients.Serious hemorrhages after ischemic stroke or TIA - Incidence, mortality, and predictors.Mechanisms of Adverse Drug Reactions
P2860
Q28185607-5056C4E9-DB73-452A-83EC-92D63DCC83F5Q28192644-5DB89675-06B3-4FBA-97A4-2EB4E8F16B25Q28193266-3A1F6151-B712-4E57-89DD-E542F965265EQ28193534-D888965C-EE70-43CF-9AA1-95E3D45DD9FCQ28196830-6AC3DDEB-EF66-404D-8560-EBEA3B8F0E22Q28199139-8EEA7F27-3CDE-4628-AD20-FE8FDA7AD5ADQ28222497-40B293C2-EB65-4CDE-896F-51A774F1B4D9Q30306587-DD477B7C-56F4-4051-8CA0-5D306E689A21Q33793086-0E132025-9838-4F4D-B88F-0CD82F2CC4F1Q34031468-047B2D30-2DFD-4A40-A68F-C6EDCDFFD83EQ34122505-88D0FFCE-D33E-455B-93D8-7BBCD253FF9EQ34316620-7268081A-EF5A-4C24-81D4-FA45AE89BD2AQ34746151-6910D20F-5AD5-4011-B9C8-567BB4DF52C2Q35510325-B8C2C9C8-65AF-4C66-BC93-0618C53C22FDQ35790677-D6393C28-1497-4013-821C-EA457C79E894Q35824470-E69F9C5F-8A6A-4CC7-AE4C-BD75EB15025DQ35877363-42E2EB81-FE76-46A1-9818-F4E183DF9167Q35879764-4094839E-3144-4527-BEAF-40B3059D210FQ36271814-0D685D18-70A8-42A1-85A6-3A7CEC7DDDF3Q36331019-CD7912BC-35B4-478D-9647-0411728714D8Q36780434-4D13ED40-0772-43E9-9587-D0EB26C89165Q37264555-6419FDDE-66EF-4A0E-8569-8EA087F98736Q38133767-AD0CF4D2-B09F-4877-8B0F-5F82736D12ECQ42181091-9538BF05-A582-44B6-991D-A23C8012BFE8Q46599096-61F1678E-5415-49C4-A649-342B5ED35154Q48294670-128FE712-7DCB-4646-8778-E3DBEA2845E8Q48783012-12B79871-EC9E-48DA-9D4B-93166C80D278Q49892570-09F79104-B634-44E1-8136-8E78FB87AFBBQ55279655-55F72882-1A4A-445A-A63E-2F03A1BEA7C2Q57302639-50C75B7B-AFF7-4F40-AEB6-2B27D2839F4E
P2860
Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Frequency of major complicatio ...... ion. A population-based study.
@en
Frequency of major complicatio ...... ion. A population-based study.
@nl
type
label
Frequency of major complicatio ...... ion. A population-based study.
@en
Frequency of major complicatio ...... ion. A population-based study.
@nl
prefLabel
Frequency of major complicatio ...... ion. A population-based study.
@en
Frequency of major complicatio ...... ion. A population-based study.
@nl
P2093
P1476
Frequency of major complicatio ...... ion. A population-based study.
@en
P2093
Brown RD Jr
O'Fallon WM
Whisnant JP
Wiebers DO
P356
10.7326/0003-4819-130-1-199901050-00004
P407
P577
1999-01-01T00:00:00Z